Overview of the Genetics of Major Depressive Disorder

Overview

Journal Curr Psychiatry Rep

Publisher Current Science

Specialty Psychiatry

Date 2010 Sep 18

PMID 20848240

Citations 137

Authors

Falk W Lohoff

Affiliations

Soon will be listed here.

Abstract

Major depressive disorder (MDD) is a common psychiatric illness with high levels of morbidity and mortality. Despite intensive research during the past several decades, the neurobiological basis and pathophysiology of depressive disorders remain unknown. Genetic factors play important roles in the development of MDD, as indicated by family, twin, and adoption studies, and may reveal important information about disease mechanisms. This article describes recent developments in the field of psychiatric genetics, with a focus on MDD. Early twin studies, linkage studies, and association studies are discussed. Recent findings from genome-wide association studies are reviewed and future directions discussed. Despite all efforts, thus far, no single genetic variation has been identified to increase the risk of depression substantially. Genetic variants are expected to have only small effects on overall disease risk, and multiple genetic factors in conjunction with environmental factors are likely necessary for the development of MDD. Future large-scale studies are needed to dissect this complex phenotype and to identify pathways involved in the etiology of MDD.

Citing Articles

Epigenomics and the Brain-gut Axis: Impact of Adverse Childhood Experiences and Therapeutic Challenges.

Wiley J, Higgins G J Transl Gastroenterol. 2025; 2(2):125-130.

PMID: 40012740 PMC: 11864786. DOI: 10.14218/JTG.2024.00017.

Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.

Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology.

Chibaatar E, Fujii R, Ikenouchi A, Okamoto N, Natsuyama T, Hayasaki G Int J Mol Sci. 2025; 25(24.

PMID: 39769424 PMC: 11727983. DOI: 10.3390/ijms252413663.

Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective.

Prodan-Barbulescu C, Ghenciu L, Seclaman E, Bujor G, Enatescu V, Danila A Curr Issues Mol Biol. 2024; 46(10):10846-10853.

PMID: 39451524 PMC: 11506240. DOI: 10.3390/cimb46100644.

Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis.

Suktas A, Ekalaksananan T, Aromseree S, Bumrungthai S, Songserm N, Pientong C BMC Psychiatry. 2024; 24(1):716.

PMID: 39438912 PMC: 11515766. DOI: 10.1186/s12888-024-06195-z.

References

Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O . Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J. 2009; 9(4):225-33. DOI: 10.1038/tpj.2009.12. View

Uher R, McGuffin P . The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry. 2009; 15(1):18-22. DOI: 10.1038/mp.2009.123. View

Camp N, Lowry M, Richards R, Plenk A, Carter C, Hensel C . Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet. 2005; 135B(1):85-93. DOI: 10.1002/ajmg.b.30177. View

Nibuya M, Morinobu S, Duman R . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995; 15(11):7539-47. PMC: 6578063. View

Lohoff F, Ferraro T . Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin Pharmacother. 2010; 11(3):423-39. DOI: 10.1517/14656560903508762. View

Lopez-Leon S, Janssens A, Gonzalez-Zuloeta Ladd A, Del-Favero J, Claes S, Oostra B . Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry. 2007; 13(8):772-85. DOI: 10.1038/sj.mp.4002088. View

Serretti A, Kato M, De Ronchi D, Kinoshita T . Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry. 2006; 12(3):247-57. DOI: 10.1038/sj.mp.4001926. View

Castren E, Rantamaki T . The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol. 2010; 70(5):289-97. DOI: 10.1002/dneu.20758. View

Anguelova M, Benkelfat C, Turecki G . A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry. 2003; 8(6):574-91. DOI: 10.1038/sj.mp.4001328. View

10.

Lewis C, Ng M, Butler A, Cohen-Woods S, Uher R, Pirlo K . Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry. 2010; 167(8):949-57. DOI: 10.1176/appi.ajp.2010.09091380. View

11.

Zhang X, Gainetdinov R, Beaulieu J, Sotnikova T, Burch L, Williams R . Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005; 45(1):11-6. DOI: 10.1016/j.neuron.2004.12.014. View

12.

Risch N, Herrell R, Lehner T, Liang K, Eaves L, Hoh J . Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009; 301(23):2462-71. PMC: 2938776. DOI: 10.1001/jama.2009.878. View

13.

Willett W . Balancing life-style and genomics research for disease prevention. Science. 2002; 296(5568):695-8. DOI: 10.1126/science.1071055. View

14.

Lesch K, Bengel D, Heils A, Sabol S, Greenberg B, Petri S . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996; 274(5292):1527-31. DOI: 10.1126/science.274.5292.1527. View

15.

McMahon F, Buervenich S, Charney D, Lipsky R, Rush A, Wilson A . Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet. 2006; 78(5):804-814. PMC: 1474035. DOI: 10.1086/503820. View

16.

Muglia P, Tozzi F, Galwey N, Francks C, Upmanyu R, Kong X . Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry. 2008; 15(6):589-601. DOI: 10.1038/mp.2008.131. View

17.

Pearson T, Manolio T . How to interpret a genome-wide association study. JAMA. 2008; 299(11):1335-44. DOI: 10.1001/jama.299.11.1335. View

18.

Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S . Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet. 2003; 72(4):879-90. PMC: 1180351. DOI: 10.1086/374178. View

19.

Hamilton S, Fyer A, Durner M, Heiman G, de Leon A, Hodge S . Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A. 2003; 100(5):2550-5. PMC: 151378. DOI: 10.1073/pnas.0335669100. View

20.

Caspi A, Hariri A, Holmes A, Uher R, Moffitt T . Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010; 167(5):509-27. PMC: 2943341. DOI: 10.1176/appi.ajp.2010.09101452. View